biotechnology | Science and Enterprise

The World Solved the Ozone Problem. It Can Solve Climate Change. https://t.co/BVlMgafyiM
about 18 hours ago
A solid majority of Americans now says that climate change affects their communities, a finding that could affect f… https://t.co/FeSjrqpv7t
about 2 days ago
New post on Science and Enterprise: Infographic – Most in US Say Climate Change Affects Them https://t.co/5N2p07v38r #Science #Business
about 2 days ago
Many thanks @deansguide for the shout-out and all of your good work for lung health. I just report on stuff. Enjoy… https://t.co/nrNcveHCJM
about 2 days ago
A company developing 3-D printed outer ear tissue received a rare pediatric disease designation on its treatment de… https://t.co/Iya45fwEl2
about 2 days ago

Early Results Show Anti-Depressive Drug Effects

By Alan, on October 15th, 2019%

Initial results from a clinical trial show a drug designed to supplement first-line treatments helps reduce symptoms of major depressive disorder. . . . → Read More: Early Results Show Anti-Depressive Drug Effects

Q3 Venture Investing Falls, Biotech Remains Hot

By Alan, on October 14th, 2019%

Venture capital investments fell in the third quarter of 2019, both in dollar volumes and number of deals, with declines occurring in the U.S. and worldwide. . . . → Read More: Q3 Venture Investing Falls, Biotech Remains Hot

Nanoparticles Designed to Cross Blood-Brain Barrier

By Alan, on October 11th, 2019%

Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain. . . . → Read More: Nanoparticles Designed to Cross Blood-Brain Barrier

Companies Developing Hemophilia Gene Editing Therapy

By Alan, on October 10th, 2019%

A partnership between drug maker Novo Nordisk and biotechnology company bluebird bio is designing a treatment for hemophilia with gene-editing proteins. . . . → Read More: Companies Developing Hemophilia Gene Editing Therapy

Merck Gaining Gut Microbe Technology for Vaccines

By Alan, on October 8th, 2019%

Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines

Peanut Allergy Patch Under FDA Review

By Alan, on October 7th, 2019%

A device to build a tolerance of peanuts in children with a peanut allergy, worn like a patch on the skin, is under review by the Food and Drug Administration. . . . → Read More: Peanut Allergy Patch Under FDA Review

Dementia Drug Candidate in Preclinical Tests

By Alan, on October 7th, 2019%

A study is underway of a new treatment approach for dementia that targets inflammation and microscopic bleeding in the brain that can accompany Alzheimer’s disease. . . . → Read More: Dementia Drug Candidate in Preclinical Tests

Small Biz Grant Funds Prenatal Genetic Test

By Alan, on October 3rd, 2019%

A small business set-aside grant is funding early development of a non-invasive prenatal test that simplifies detection of genetic abnormalities in a fetus. . . . → Read More: Small Biz Grant Funds Prenatal Genetic Test

Nanotech Crispr Delivery in Development

By Alan, on October 2nd, 2019%

Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment. . . . → Read More: Nanotech Crispr Delivery in Development

Novartis, Microsoft Partner on A.I.

By Alan, on October 2nd, 2019%

Drug maker Novartis is collaborating with Microsoft to extend the company’s adoption of artificial intelligence into many of its corporate functions. . . . → Read More: Novartis, Microsoft Partner on A.I.

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise